Cartesian Share Price

Cartesian Share Price

NASDAQ: RNAC | Micro Cap | Healthcare
$5.89
-$0.44 (-6.95%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cartesian Stock Performance

Open
$6.27
Prev. Close
$6.33
Circuit Range
N/A
Day Range
$5.84 - $6.27
Year Range
$5.66 - $10.88
Volume
9,200
Average Traded
$5.92

Cartesian Share Price Today

As of 20 November 2026, Cartesian Therapeutics, Inc.'s share price is $5.89. The stock opened at $6.27, compared to its previous close of $6.33. During today's trading session, Cartesian Therapeutics, Inc.'s share price traded between $5.84 and $6.27, with an average price of $6.06. Over the past 52 weeks, the stock has recorded a high of $10.88 and a low of $5.66. In terms of performance, Cartesian Therapeutics, Inc.'s share price has declined by 21.68% over the last six months and is down 21.68% on a year-on-year basis.

Cartesian Share Price Chart

Line chart of the Cartesian price trend over the selected period. The price fell overall, ranging from 6.03 to 6.37, ending at 6.30.
$5.84$6.27
L
Show Current Price
H

Cartesian Stock Fundamentals & Key Indicators

Market Cap
$152.98M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.25
Revenue (TTM)
$2.80B
Return On Equity (TTM)
99.27%
Profit Margin
-4653.57%
Debt to Equity
-0.38
Quarterly Earnings Growth YoY
87.61%

Cartesian Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.95$0.08$0.00$0.00
Net Profit-$92.58-$39.18$13.72-$11.47
Net Profit Margin-9745.26%-48975.00%N/AN/A
Income ChangeN/A57.68%135.02%-183.60%

Cartesian Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$26.00$38.91$2.80
Net Profit-$257.26-$77.42-$130.30
Net Profit Margin-989.46%-198.97%-4653.57%
Income ChangeN/A69.91%-68.30%

Cartesian Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets167.14218.4214.32
Current Assets129.28216.6390.73
Total Assets296.41435.02305.05
Non Current Liabilities407.71418.85376.47
Current Liabilities14.9422.9868.21
Total Liabilities422.65441.83444.68
Shareholders' Equity-126.24-6.8-436.48

Cartesian Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-73.94-23.67-51.16
Investing-5.45-8.7434.61
Financing-8.06168.43-13.15

Corporate Actions

Split
Ex-date: 05 Apr 2024

Split
Ex-date: 01 Dec 2023

About Cartesian

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Cartesian Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.30
$5.88
-10.23%
Oct 2026
$7.20
$6.55
-9.66%
Sep 2026
$9.02
$7.25
-27.43%
Aug 2026
$7.86
$9.99
+28.74%
Jul 2026
$10.30
$7.76
-25.53%
Jun 2026
$7.43
$10.42
+38.56%
May 2026
$6.33
$7.52
+20.80%
Apr 2026
$6.38
$6.22
+0.81%
Mar 2026
$7.36
$6.17
-18.64%
Feb 2026
$6.96
$7.59
+10.16%
Jan 2026
$7.23
$6.89
-4.31%
Dec 2025
$7.30
$7.20
-4.26%

Cartesian Share Price FAQs